Govardhana Babu
Bodedla
*ab,
Shengyi
Ke
ab,
Yibing
Cao
ab,
Lijie
Zhang
c and
Wai-Yeung
Wong
*ab
aDepartment of Applied Biology & Chemical Technology and Research Institute for Smart Energy, The Hong Kong Polytechnic University, Hong Kong, P. R. China. E-mail: govardhana.bodedla@polyu.edu.hk; wai-yeung.wong@polyu.edu.hk
bThe Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518057, P. R. China
cZhejiang International Joint Laboratory of Optical Functional Materials, Wenzhou University, Wenzhou 325000, P. R. China
First published on 18th November 2025
Phthalocyanines and subphthalocyanines have emerged as highly adaptable molecular platforms with diverse applications, predominantly due to their tunable photophysical properties achieved through the variation in axial and peripheral substituents and central metal atoms. Despite these benefits, their broader application has been hindered by their intrinsic hydrophobicity and strong aggregation in aqueous environments, leading to aggregation-caused quenching (ACQ) and poor photoluminescence performance. Recent advances have demonstrated that integrating aggregation-induced emission luminogens (AIEgens), such as tetraphenylethene and triphenylamine, into phthalocyanine and subphthalocyanine frameworks can efficiently overcome ACQ. This strategy restricts intramolecular motions, converting traditional ACQ-type systems into AIE-active materials with significantly improved emission. Moreover, the unique cone-shaped, π-conjugated architecture of subphthalocyanines enables efficient fluorescence resonance energy transfer when combined with AIE-active groups, further enhancing their photophysical properties. In this perspective, we highlight the recent progress in the development of AIEgen-integrated phthalocyanines and subphthalocyanines, discuss their structure–activity relationships, and explore their potential for advanced applications. To our knowledge, this is the first review to focus on the growing importance and future opportunities of integrating AIEgens with phthalocyanine and subphthalocyanine systems.
On the other hand, subphthalocyanines, which are the lowest homologs of phthalocyanines, possess an electron-rich nature and a noncentrosymmetric C3v cone-shaped structure, and exhibit strong absorption and emission in the visible region.56 This makes them attractive for various applications, including organic semiconductors,57,58 solar cells,59–61 nonlinear optical materials,62–64 and fluorescent probes.65–68 Because of their exceptional structure, they have also been used for asymmetric phthalocyanine synthesis and catalytic degradation.69–71 However, similar to phthalocyanines, subphthalocyanines frequently exhibit ACQ upon aggregation, which restricts their use in the aforementioned applications.
An alternative and efficient approach to overcoming ACQ is the integration of aggregation-induced emission (AIE) luminogens (AIEgens) into the frameworks of phthalocyanines and subphthalocyanines. Certain molecules exhibit enhanced emission upon aggregation and in the solid state, a phenomenon known as AIE, due to the presence of AIEgens in their molecular structure.72,73 This is in contrast to conventional fluorophores. The AIE effect is mainly attributed to the restriction of intramolecular rotations and vibrations in the aggregated or solid state, which hampers non-radiative decay pathways and leads to intensified emission. This ultimately provides long-lived photoexcited state electron lifetime (τPL) values, thereby enhancing ΦPL and ROS generation for AIEgen-conjugated molecules. The most typical AIEgens, namely tetraphenylethene (TPE),59,74 triphenylamine (TPA),75 and phthalonitrile derivatives76,77 (Fig. 1), have been effectively introduced into the frameworks of phthalocyanines and subphthalocyanines. This strategy is particularly beneficial for transforming such large π-conjugated and planar molecules from ACQ-type to AIE-type upon aggregation. Since AIE was first discovered by Tang and co-workers in 2001,78 AIE-active molecules have been employed in many applications, including the biomedical field, such as imaging-guided PDT, targeted chemotherapy, long-term mitochondrial tracking, and enzyme-activated diagnostic probes,79–82 as well as in catalysis,73,83 OLED devices,84–86 and sensor applications.87–89 After a careful literature survey, we found that very few papers have been published on AIEgen-integrated phthalocyanines and subphthalocyanines, and their applications remain limited. Thus, herein, we have summarized the phthalocyanines and subphthalocyanines reported in the literature so far and discussed their AIE properties, with the aim of developing promising phthalocyanines and subphthalocyanines with AIE characteristics for a wide range of future applications.
![]() | ||
| Fig. 1 Pictorial representation of AIEgens attached at different positions of phthalocyanines and subphthalocyanines. | ||
| Compound | λ abs (nm) | λ em (nm) | τ PL (ns) | Φ PL | Φ Δ | Ref. |
|---|---|---|---|---|---|---|
| a Absorption peak wavelength. b Emission peak wavelength. c Photoexcited state electron lifetime. d Photoluminescence quantum yield. e 1O2 quantum yield. f Not applicable. | ||||||
| 1 | 353, 678 | 678 | 5.34 | 0.06 | 0.043 | 75 |
| 2 | 357, 681 | 685 | 1.56 | 0.08 | 0.016 | 75 |
| 3 | 357, 683 | 687 | 8.58 | 0.48 | 0.530 | 75 |
| 4 | 685 | 675 | naf | 0.007 | 0.09 | 94 |
| 5 | 695 | 706 | naf | 0.297 | 0.37 | 94 |
| 6 | 692 | 705 | naf | 0.004 | 0.08 | 94 |
| 7 | 689 | 700 | naf | 0.351 | 0.21 | 94 |
| 8 | 677 | naf | naf | naf | naf | 76 |
| 9 | 679 | 439, 694 | naf | naf | naf | 77 |
| 10 | 680 | 433, 695 | naf | naf | naf | 77 |
| 11 | 678 | 443, 695 | naf | naf | naf | 77 |
| 12 | 680 | 445, 695 | naf | naf | naf | 77 |
| 13 | 681 | 438, 695 | naf | naf | naf | 77 |
| 14 | 569 | 584 | naf | 2.20 | naf | 74 |
| 15 | 589 | 615 | naf | 13.70 | naf | 74 |
| 16 | 568 | 582 | naf | 0.60 | naf | 74 |
Three Si(IV)-phthalocyanines 1–3 with axially substituted TPA terminal groups and either fluorinated or non-fluorinated bisphenol A (BPA) bridge groups were designed, synthesized, and characterized by Liu et al.75 The photophysical properties of these Si(IV)-phthalocyanines mainly depended on the nature of the BPA bridge and the presence of TPA groups. All three Si(IV)-phthalocyanines exhibited dual emission peaks in their emission spectra. The emission peaks in the range of 675–688 nm were attributed to the typical Si(IV)-phthalocyanine core, while the peak at 396 nm was assigned to the TPA moieties. Among the Si(IV)-phthalocyanines, 3, which contains both TPA and fluorinated BPA, exhibited the highest ΦPL, ΦΔ, and τPL value in tetrahydrofuran (THF) solution. This is attributed to the rigid molecular skeleton of 3, which can hamper ACQ. In particular, Si(IV)-phthalocyanine 1, with only TPA moieties, exhibited a strong AIE phenomenon in THF/water (H2O) mixtures, owing to the restriction of intramolecular rotation caused by the TPA groups in the solid state (Fig. 3(A)). These results indicate that understanding the relationship between molecular structure and photophysical properties of Si(IV)-phthalocyanines can offer important insights for the rational design of novel phthalocyanines with enhanced AIE characteristics for PDT and related applications.
![]() | ||
| Fig. 3 (A) Change of fluorescence intensity at 396 nm of 3 in THF/H2O mixtures (inset shows the fluorescence intensity at 600–800 nm). (B) The self-assembling mechanism of DSPE@3 nanoparticles and their possible mechanism of action in mediating in vitro photodynamic therapy on MCF-7 breast cancer cells. (C) The particle size distribution of DSPE@3 in H2O (inset is TEM of DSPE@3). (D) Possible trafficking and distribution mechanism of 3@AuNR@SiO2 in MCF-7 cells. (E) The size distribution profile and (F) TEM image of 3@AuNR@SiO2. (G) The fluorescence images of (a) AuNR, (b) AuNR@SiO2, (c) 3, and (d) 3@AuNR@SiO2 at λex = 365 nm. (H) The phototoxicity of 3@AuNR@SiO2 against MCF-7 breast cancer cells was studied using the Cell Counting Kit-8 (CCK-8) assay (CAu = 0, 20, 40, 60, 80, 100 µg mL−1). (I) The fluorescence emission of aggregated 8 in mixed dimethylformamide (DMF)/H2O solvents with reaction time of 10 h. (J) The solid state fluorescence emission spectra of 8 synthesized after different reaction time. Part (A): Reproduced with permission.75 Copyright 2022, Elsevier SD. Parts (B & C): Reproduced with permission.92 Copyright 2023, Elsevier SD. Parts (D–H): Reproduced with permission.93 Copyright 2025, Elsevier SD. Parts (I & J): Reproduced with permission.76 Copyright 2016, Elsevier SD. | ||
As lysosome-targeting therapy represents a promising approach to overcoming drug resistance in cancer treatment, the development of nanodrugs with efficient lysosomal targeting is very important. Thus, a nanoparticle, DSPE@3, was developed by encapsulating Si(IV)-phthalocyanine 3 in a distearoylphosphatidylethanolamine–polyethylene glycol 2000 (DSPE-PEG2000) matrix (Fig. 3(B)).92 DSPE@3 nanoparticles exhibited a spherical morphology, and the hydrodynamic size of the nanoparticles was found to be 90.44 nm (Fig. 3(C)). These nanoparticles demonstrated outstanding cellular uptake and selective accumulation in the lysosomes of Michigan Cancer Foundation-7 (MCF-7) breast cancer cells. Notably, fluorescent probes showed that DSPE@3 displayed two-color fluorescence imaging and produced sustained intracellular ROS under irradiation with an 860 nm femtosecond laser. The production of ROS enabled lysosome-mediated apoptosis by efficiently disrupting lysosomal function and causing cell death. More importantly, DSPE@3 nanoparticles showed robust phototoxicity and negligible dark toxicity, demonstrating both the therapeutic potential and biocompatibility of DSPE@3 nanoparticles. These findings illustrate that DSPE@3 is a promising photosensitizer for lysosome-targeted PDT, highlighting its potential for the treatment of drug-resistant breast cancer. Moreover, further studies are required to explore the clinical applications and efficacy of DSPE@3 nanoparticles in cancer therapy. The same group further developed a nanoprobe, 3@AuNR@SiO2, by encapsulating compound 3 within mesoporous silica-coated gold nanorods (AuNR@SiO2) (Fig. 3(D–F)).93 This design aims to enable timely escape from lysosomes, preventing premature degradation in acidic cellular environments. It has been found that 3@AuNR@SiO2 displays strong AIE two-photon fluorescence when encapsulated in AuNR@SiO2 (Fig. 3(G)), enabling real-time tracking in breast cancer cells (Fig. 3(H)), which is lacking in polymer nanocarriers. The nanoprobe 3@AuNR@SiO2 freely escapes from lysosomes and selectively targets at mitochondria under irradiation. Additionally, it generates substantial ROS and triggers hyperthermia, establishing potent PDT and photothermal therapy effects. Tumor cell death was confirmed by flow cytometry, which demonstrated both necrosis and apoptosis. These results demonstrate that 3@AuNR@SiO2 acts as a multifunctional probe for lysosome escape, mitochondria targeting, and two-photon fluorescence imaging-guided synergistic cancer therapy. This offers an encouraging approach for breast cancer treatment.
Openda et al. developed three Si(IV)-phthalocyanine derivatives, 4–6 containing TPE units at peripheral and/or axial positions to examine the effect of molecular engineering on their photophysical and AIE properties.94 The photophysical and AIE properties of compounds 4–6 were carefully investigated and compared to those of the control Si(IV)-phthalocyanine 7. Diminished photoluminescence and generation of 1O2 were observed for Si(IV)-phthalocyanine 4, but it exhibited AIE in the NIR region (700–900 nm) upon aggregation in aqueous environments. In contrast, under the same aqueous conditions, Si(IV)-phthalocyanine 5, which possesses four peripheral TPE units, did not exhibit AIE behaviour but displayed enhanced ΦPL and 1O2 generation. On the other hand, Si(IV)-phthalocyanine 6, with both axial and peripheral TPE units, showed reduced photoluminescence, lower 1O2 generation, and no AIE. These results are completely different from those observed for Si(IV)-phthalocyanines 4 and 5. This reveals the essential role of the substitution patterns of TPE units in fine-tuning the photodynamic and AIE properties of Si(IV)-phthalocyanines. The ability to control AIE behaviour via molecular engineering suggests that TPE-functionalized Si(IV)-phthalocyanines are promising candidates for applications in biomedical fields and image-guided phototherapy. The balance between AIE and 1O2 generation could further enhance their therapeutic efficacy and extend their potential use in PDT.
Generally, Cu(II)-phthalocyanines are mostly non-fluorescent owing to the fast energy transfer from the first singlet excited state (S1) to the triplet state (T1) through open-shell paramagnetic Cu(II) mediated spin–orbit interaction.76 Thus, to achieve emission from Cu(II)-phthalocyanines, a dendritic Cu(II)-phthalocyanine 8 was facilely synthesized through a cycloaddition reaction between a biphenyl phthalonitrile precursor and Cu(II) ions. This dendritic Cu(II)-phthalocyanine exhibited excellent solubility in polar aprotic solvents but no emission in solution. Notably, Cu(II)-phthalocyanine 8 showed strong blue fluorescence at around 480 nm and pronounced AIE in the solid state and upon aggregation (Fig. 3(I)). This is attributed to the restriction of intramolecular rotation in the aggregated state, a typical AIE phenomenon. Moreover, when 8 was synthesized with extended reaction times, it displayed enhanced and blue-shifted solid state blue fluorescence with greater thermal stability, ascribed to enhanced crystallinity (Fig. 3(J)). These results indicate the significance of reaction conditions in modulating the molecular geometry, crystallinity, and photophysical properties of dendritic Cu(II)-phthalocyanine 8. Because of its easy synthesis, tunable blue emission, and robust thermal stability, dendritic Cu(II)-phthalocyanine 8 can be employed as a valuable candidate for advanced optoelectronic devices and full-color display technologies. In continuation of the above work, the same group further synthesized a family of dendritic Zn(II)-phthalocyanines, 9–13 substituted with hydroquinone, naphthalenediol, dihydroxybiphenyl, bisphenol F, and BPA moieties through a two-step reaction using donor–linker–acceptor (D–π–A)-type bisphthalonitrile precursors and Zn(II) ions.77 The photophysical properties of these dendritic Zn(II)-phthalocyanines were systematically studied in solution, mixed solvents, solid state, and as polymethyl methacrylate (PMMA) composite films. They exhibited both molecular NIR photoluminescence and AIE characteristics. Particularly, dendritic Zn(II)-phthalocyanines, 9–11 containing hydroquinone, naphthalenediol, or dihydroxybiphenyl moieties exhibited an outstanding conversion from strong NIR emission in the molecular state to intense blue fluorescence in the solid state and upon aggregation. In contrast, Zn(II)-phthalocyanines with bisphenol F and BPA moieties exhibited only NIR emission in the molecular state and no emission upon aggregation or in the solid state, signifying typical ACQ behavior. Density functional theory (DFT) calculations further supported the relationship between molecular structure and the observed luminescence properties through electron density distribution. Additionally, dendritic Zn(II)-phthalocyanines displayed well-organized three-dimensional microspheres and two-dimensional leaf-like microstructures upon aggregation in aqueous mixtures. Moreover, the dendritic Zn(II)-phthalocyanines not only exhibited strong emission in the solid state but also when embedded in PMMA films. These results signify that dendritic Zn(II)-phthalocyanines, 9–11 can be used as multipurpose fluorophores for high-performance biological imaging, fluorescent flexible optoelectronic devices, and chemosensors due to their tunable emission, solid state fluorescence, and easy processability.
Overall, these findings highlight that precise molecular engineering of phthalocyanines permits fine-tuning of their AIE properties, which is vital for developing top-notch materials for biomedical and optoelectronic applications. In particular, certain Si(IV)-phthalocyanines with TPE moieties and DSPE@3 exhibit high efficacy for lysosome-targeted PDT, especially against drug-resistant cancers and in image-guided phototherapy. Furthermore, dendritic Zn(II)- and Cu(II)-phthalocyanines display variable solid state fluorescence, making them promising candidates for outstanding imaging, chemosensors, and optoelectronic devices. Lastly, understanding the structure–property relationships is crucial for the development of next-generation, exceptional, and functional phthalocyanine-based materials.
Dinag et al. synthesized two subphthalocyanines, 15 and 16, containing axially and peripherally substituted TPE moieties, and investigated their AIE properties under various conditions.74 In THF solution, subphthalocyanine 15, with peripherally substituted TPE moieties, exhibited a higher ΦPL than subphthalocyanine 16, which contained axially modified TPE moieties. In these subphthalocyanines, the TPE moiety acts as an energy donor, while the subphthalocyanine core acts as an energy acceptor. A fluorescence resonance energy transfer (FRET) phenomenon is possible in both 15 and 16 due to the overlap between the emission spectrum of the TPE moiety and the absorption spectrum of the control subphthalocyanine 14, which lacks TPE (Fig. 5(A)). Notably, compound 16 exhibited both FRET and ACQ phenomena when excited at 480 nm, corresponding to the subphthalocyanine absorption, and a significant AIE was observed upon excitation at 270 nm, which is related to the TPE unit (Fig. 5(B)). Under the same conditions, in contrast, compound 15 did not show AIE properties, although it exhibited a higher ΦPL than 16. These findings illustrate the different effects of axial versus peripheral functionalization on the photophysical properties of subphthalocyanines. This is beneficial for designing promising fluorescent probes and sensing materials using axially modified subphthalocyanines.
![]() | ||
| Fig. 5 (A) (a) The spectral overlap of the normalized fluorescence spectrum of hydroxy TPE (red line) in the aggregate state and the excitation spectrum of subphthalocyanine 14 in THF (black line) and (b) the schematic diagram of FRET process in 16. (B) The emission spectra of 16 recorded in different ratios of THF/H2O mixtures under (a) 270 nm and (b) 480 nm excitation. Parts (A & B): Reproduced with permission.74 Copyright 2021, Elsevier SD. | ||
In another report, phthalonitriles with different TPE substitution positions were first synthesized and subsequently used as precursors to develop a series of axially and peripherally TPE-integrated subphthalocyanines, 17–20.59 The crystallographic structures of the phthalonitriles revealed that the bulky TPE moieties suppressed intermolecular π–π interactions in the solid state. AIE studies showed that the precursor phthalonitriles exhibited excellent AIE properties, as evidenced by enhanced emission intensity with increasing H2O content in THF/H2O mixtures. In contrast, all the TPE-substituted subphthalocyanines, 17–20, showed quenched emission with increasing H2O content in THF/H2O mixtures, indicating that the ACQ phenomenon dominates in these subphthalocyanines. These results demonstrate that although bulky TPE groups were introduced parallel and perpendicular to the π-plane of subphthalocyanines, strong aggregation of the π-plane is not favored. Moreover, DFT calculations revealed that the lack of AIE properties in these subphthalocyanines is due to strong intramolecular interactions between the subphthalocyanine macrocycle and the TPE groups. This leads to a significant intramolecular charge transfer contribution, which is close to the Q-band. Another reason is that the fixation of TPE groups around the subphthalocyanine macrocycle makes it difficult to adopt a favorable conformation for AIE properties in the aggregated state. These results highlight that the development of novel AIEgens is required to enable subphthalocyanines to overcome ACQ and exhibit AIE.
Altogether, these findings illustrate that the position and mode of TPE integration significantly affect the photophysical properties of subphthalocyanines. Although some subphthalocyanines promote AIE, others still suffer from ACQ, highlighting the urgent need for further molecular design to fully understand and develop AIE-active subphthalocyanines for advanced applications
However, several challenges and opportunities still remain. Attaining an ideal balance among AIE, ΦPL, and 1O2 is a key factor for biomedical and display applications. The development and introduction of diverse AIE-active scaffolds into phthalocyanine and subphthalocyanine frameworks could lead to innovative materials with unique properties and broader utility. The expansion of cutting-edge nanoplatforms for targeted delivery and real-time monitoring, as well as a deeper understanding of AIE and related phenomena, will further drive innovation. Apart from PDT and imaging, these materials can also serve as potential candidates for applications in organic electronics, artificial photosynthesis, sensing, and environmental remediation.
| This journal is © The Royal Society of Chemistry 2026 |